Search

everythinglearnresearchcommunity

for

Search:↓

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

GLP-1RA therapy may increase the risk of hair loss.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

The seed extract of Lepidium sativum L. can potentially treat hair loss, showing effects similar to 5% minoxidil.

Tirzepatide may improve hair loss by reducing insulin resistance.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

Newer GLP-1 drugs like semaglutide may cause hair loss.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

GLP-1 receptor agonists may cause hair loss, but regrowth is rare.

Letrozole may help prevent seizures by reducing certain hormone levels.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Thyroid receptor agonists may treat male pattern baldness without harmful side effects.

Leflunomide and anthralin may effectively treat severe alopecia areata.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.